BioGenix wins in BioTek patent case
This article was originally published in Clinica
Executive Summary
BioTek Solutions has been ordered to pay damages of around $850,000 for willfully infringing BioGenix Laboratories' patent on the Antigen Retrieval procedure for treating tissue samples.